直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Federal Circuit IP Blog

Spotlight on Upcoming Oral Arguments - October 2015

September 29, 2015

Authored and Edited by Elizabeth D. Ferrill

Spotlight on Upcoming Oral Arguments – July 2015

In re Tam, No. 14-1203 – 10:00 A.M. Courtroom 201

Under 15 U.S.C. § 1052(a), trademarks that “may disparage or falsely suggest a connection with persons, living or dead, institutions, beliefs, or national symbols, or bring them into contempt, or disrepute” must be refused registration on the principal register.  In recent years, this provision has been used to cancel the registration of the Washington REDSKINS mark and, in this appeal, to refuse registration of THE SLANTS mark used by an Asian-American dance-rock band.  The Federal Circuit will convene en banc to consider a single constitutional issue: whether the bar on registration of disparaging marks in § 1052(a) violates the First Amendment.  The PTO has intervened in the case, and numerous amici have weighed in on the issue.

Lexmark International v. Impression Products, No. 14-1617 – 2:00 P.M. Courtroom 201

After panel briefing in this appeal, the Federal Circuit ordered en banc review of two fundamental issues relating to patent exhaustion: (1) whether authorized foreign sales can exhaust U.S. patent rights; and (2) whether the sale of a patented article, made under a restriction that is otherwise lawful and within the scope of the patent grant, gives rise to patent exhaustion.  Dozens of amici have added their views on these issues, and several will participate in oral argument: Biotechnology Industry Organization and CropLife International have jointly received five minutes of Lexmark’s original 30 minutes; Dell, Google, Intel, L Brands, LG Electronics, Newegg, Ninestar Image Tech, QVC, Samsung Electronics, SAS Institute, and Xilinx have jointly received ten minutes of Impression’s original 30 minutes; and the United States government has received an additional ten minutes of time.

Wednesday, October 7, 2015

Commonwealth Scientific and Industrial Research Organization v. Cisco Systems, No. 15-1066 – 10:00 A.M. Boston, MA

In another case drawing significant amicus participation, a Federal Circuit panel (sitting at the Boston University School of Law) will consider whether the Eastern District of Texas properly determined a reasonable royalty for infringement of a standard-essential patent.  This case highlights the tension between damages apportionment principles, which may suggest the use of one royalty base, and the evidentiary value of comparable licenses or offers based on a different royalty base.

Thursday, October 8, 2015

Nike v. Adidas, No. 14-1719 – 10:00 A.M. Courtroom 402

After granting Adidas’s IPR petition to review the validity of Nike’s patent, the PTAB refused Nike’s request to narrow the patent’s claims to avoid the prior art of record because the proposed amendments were obvious in view of the prior art of record and Nike failed to demonstrate that the proposed amendments overcame prior art not of record.  In this appeal, the Federal Circuit could potentially address which party bears the burden for IPR claim amendments—specifically, whether the patent owner bears the burden of demonstrating the proposed amendment’s patentability or whether the petitioner bears the burden of demonstrating its unpatentability.  The PTO has intervened to defend the PTAB’s decision.

Harmonic v. Avid Technology, No. 15-1072 – 10:00 A.M. Courtroom 402

In the IPR proceeding, from which this case is appealed, the petitioner, Harmonic, proposed seven different grounds of unpatentability.  The PTAB instituted the petition on one ground and determined that three of the remaining grounds were redundant.  On appeal, the petitioner argues that the PTAB must consider the merits of redundant grounds in addition to those from which the IPR was instituted.  The PTO has intervened, arguing that the Federal Circuit lacks jurisdiction to review the PTAB’s institution decision.

Tags

Spotlight on Upcoming Oral Arguments

Contacts

Elizabeth D. Ferrill
Partner
Washington, DC
+1 202 408 4445
Email

Copyright © 2015 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 


DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.

Related Insights

Conference

7th International Conference on Biofuels and Bioenergy

June 25-26, 2026

Edinburgh

Conference

17th Summit on Biosimilars & Innovator Biologics

June 2-3, 2026

New York

At the PTAB Blog

Consistency Is Key – USPTO Issues Three New Informative Decisions

May 29, 2026

At the PTAB Blog

Discretion All the Way Down: USPTO Uses a Discretionary IPR Denial to Justify a    
§ 325(d) EPR Denial

May 28, 2026

At the PTAB Blog

Before the Holding, the Message: Director Squires Uses Magnolia Medical to Outline PTAB Discretionary Denial Policy Changes

May 20, 2026

Conference

19th Annual Forum on Pharma & Biotech Patent Litigation in Europe

May 19-20, 2026

Amsterdam

INCONTESTABLE® Blog

Netflix Prevails in Copyright Infringement Suit Regarding Tiger King

May 14, 2026

Federal Circuit IP Blog

Federal Circuit Affirms § 102(b) Invalidity; Source Code Commands Are Not Hearsay

May 14, 2026

Federal Circuit IP Blog

When “and” and “e.g.” Matter: Federal Circuit Revives VLSI vs. Intel Case

May 14, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP